Drugs / Iodine Complex
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04473261 | Jul 2020 → Aug 2021 | COVID-19 | Sohaib Ashraf | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iodine Complex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04473261 ↗ |
| Known as | ionic-iodine polymer complex | “In this multi-armed study ionic-iodine polymer complex with 200 mg of elemental iodine will be given using three formulations to evaluate efficacy.” PMID 33568226 ↗ Feb 2021 |